<DOC>
	<DOCNO>NCT02272517</DOCNO>
	<brief_summary>This study aim evaluate effect vortioxetine cognitive dysfunction major depressive disorder ( MDD ) patient inadequate response current antidepressant treatment .</brief_summary>
	<brief_title>Efficacy Vortioxetine Versus Escitalopram Cognitive Function Patients With Inadequate Response Current Antidepressant Treatment Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>The patient MDD , diagnose accord DSMIVTR™ recurrent MDE ( classification 296.3x ) confirm use Mini International Neuropsychiatric Interview ( MINI ) . The patient depressive symptom currently consider non partially responsive ( inadequate response ) , one adequate course SSRI/SNRI antidepressant monotherapy candidate switch investigator 's opinion . The patient want stop take his/her current SSRI/SNRI treatment due inadequate response confirm Antidepressant Treatment Response Questionnaire ( ATRQ ) , &lt; 50 % response current treatment ) . The patient must treat SSRI/SNRI monotherapy ( citalopram , paroxetine , sertraline , duloxetine , venlafaxine ) least 6 week license dos prior Screening Visit . The patient PHQ9 total score ≥14 . The patient MADRS total score ≥ 22 . The patient current MDE ≤1 year . The patient Perceived Deficits Questionnaire Depression ( PDQD ) total score &gt; 25 . The patient man woman age ≥18 ≤65 year . The patient score ≥70 DSST ( Number Correct Symbols ) Baseline Visit . The patient physical , cognitive , language impairment severity adversely affect validity data derive neuropsychological test . The patient current psychiatric disorder Axis I disorder ( accord DSMIVTR™ criterion ) MDD , assess use MINI . The patient current diagnosis dysthymic disorder within 3 month precede onset current episode ( DSMIVTR™ criterion ) . The patient borderline , schizotypal , schizoid , paranoid , histrionic , antisocial personality disorder ( axis II ) comorbid primary diagnosis ( DSMIVTR™ criterion ) . The patient history previous MDEs consider treatment resistant define inadequate response ( incomplete therapeutic response ) two prior course least 6 week conventional antidepressant drug adequate dosage , patient treatmentresistant depression investigator 's judgement . The patient suffers personality disorder , mental retardation , pervasive development disorder , attentiondeficit/hyperactivity disorder , organic mental disorder , mental disorder due general medical condition ( DSMIVTR™ criterion ) . The patient diagnosis alcohol substance abuse dependence ( exclude nicotine caffeine ) ( DSMIVTR™ criterion ) sustain full remission least 2 year prior Screening Visit . The patient current diagnosis history manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature ( DSMIVTR™ criterion ) . Other protocol define inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vortioxetine</keyword>
	<keyword>Cognition</keyword>
</DOC>